Spruce Medimaging
Latest round
- Series A
Last raised
- Aug 2024
Total raised
- Undisclosed
Investors
- 2
About Spruce Medimaging
Founded in 2022 and based in Beijing, China, Spruce Medimaging operates as a medical company that focuses on providing clinical medicine evaluation services. It acquired ISO-13485 quality management system certification and ISO-27001 quality management system certification. The company cooperated with Yizhong Pharma, Ausun Pharm, Fosun Pharma, and other enterprises. The company is mainly engaged in independent imaging evaluation (IRC) services for innovative drug clinical research centers. The business covers medical imaging evaluation, clinical medicine evaluation, and eligibility evaluation of clinical research subjects for doctors and pharmaceutical companies. Its image types include CT, MRI, and X-Ray, which adopt technical platforms such as medical imaging, clinical data, and medical AI. The target customers of the company are medical institutions, biopharmaceutical companies, and medical device companies. The company generates revenue by providing clinical medicine evaluation and related services.
Who invested in Spruce Medimaging
2 investors across 1 round
See all investors in Spruce Medimaging
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 8, 2024
Amount
Undisclosed
Investors
Questions about Spruce Medimaging
Who invested in Spruce Medimaging?
Spruce Medimaging has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spruce Medimaging raised?
Spruce Medimaging has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Spruce Medimaging last raise money?
Spruce Medimaging's most recent round on record is a Series A, in Aug 2024.
What does Spruce Medimaging do?
Founded in 2022 and based in Beijing, China, Spruce Medimaging operates as a medical company that focuses on providing clinical medicine evaluation services.
Where is Spruce Medimaging headquartered?
Spruce Medimaging is headquartered in Beijing, China.
Which VCs invest in companies like Spruce Medimaging?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Spruce Medimaging's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Spruce Medimaging? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.